Slater G J, Saini S, Mayo-smith W W, Sharma P, Eisenberg P J, Hahn P F
Department of Radiology, Massachusetts General Hospital, Boston, USA.
Clin Radiol. 1996 Jul;51(7):484-6. doi: 10.1016/s0009-9260(96)80187-5.
To compare liver enhancement and lesion-liver contrast on T1-weighted (T1W) gradient recalled echo (GRE), spin-echo (SE) and fat-suppressed SE (FS-SE) pulse sequences at Manganese-DPDP (Mn-DPDP) enhanced magnetic resonance (MR) imaging of the liver. PATIENTS AND METHODS. Twenty-one patients with known liver lesions were administered 5 mumol/kg of Mn-DPDP. TIW GRE (78/2.3/80 degrees), SE and F-SE (300/12) images were obtained before and 15 min after Mn-DPDP. Signal/noise ratio (SNR) and lesion-liver contrast/noise ratio (CNR) were calculated for each pulse sequence.
Liver SNR (n = 21) and lesion-liver CNR (n = 10) increased significantly after Mn-DPDP on all three pulse sequences (P < 0.0001). Liver SNR was highest on the FS-SE and GRE pulse sequences (FS-SE = 43.8, GRE = 38.4, SE = 29.2). Lesion-liver CNR was highest on the FS-SE pulse sequence (FS-SE = -29.3, SE = -23.2, GRE = -19.8), which was significantly higher than the GRE pulse sequence (P < 0.05).
The T1-weighted fat-suppressed SE (FS-SE) pulse sequence provides highest liver enhancement and lesion-liver contrast and is recommended for Mn-DPDP enhanced MR imaging.
在锰-二吡啶二硫代磷酸酯(Mn-DPDP)增强肝脏磁共振成像中,比较T1加权(T1W)梯度回波(GRE)、自旋回波(SE)和脂肪抑制SE(FS-SE)脉冲序列上肝脏强化及病变-肝脏对比情况。患者与方法。21例已知肝脏病变患者接受5 μmol/kg的Mn-DPDP。在注射Mn-DPDP前及注射后15分钟获取T1W GRE(78/2.3/80°)、SE和FS-SE(300/12)图像。计算每个脉冲序列的信噪比(SNR)及病变-肝脏对比噪声比(CNR)。
在所有三个脉冲序列上,注射Mn-DPDP后肝脏SNR(n = 21)及病变-肝脏CNR(n = 10)均显著升高(P < 0.0001)。FS-SE和GRE脉冲序列上肝脏SNR最高(FS-SE = 43.8,GRE = 38.4,SE = 29.2)。FS-SE脉冲序列上病变-肝脏CNR最高(FS-SE = -29.3,SE = -23.2,GRE = -19.8),显著高于GRE脉冲序列(P < 0.05)。
T1加权脂肪抑制SE(FS-SE)脉冲序列可提供最高的肝脏强化及病变-肝脏对比,推荐用于Mn-DPDP增强磁共振成像。